ArticleScientific reports2026
Establishing a robust preclinical model to investigate early and late radiation-induced skin reactions.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiation-induced skin reactions (RISRs) adversely affect cancer patients by limiting treatment adherence and quality of life (QoL). The current study aimed to establish a murine model for early and late RISR by fractionated radiation, with 30 Gy (10 Gy X 3 sessions) and 50 Gy (10 Gy X 5 sessions) irradiation of the right hind limb of male Swiss albino mice. Early RISRs were monitored for 30 days via blinded RTOG grading, and tissue samples from days 15 and 30 were harvested for histological and morphometric analysis (H&E staining). For late RISR, mice exposed to 50 Gy were examined for 120 days by phenotypical, histological, and morphometric evaluations (H&E and Masson's trichrome staining). The 30 Gy group presented a median RTOG grade of 2, resolving by day 30, whereas the 50 Gy group presented a median grade of 3, resolving by day 35. Early RISR in the 50 Gy group revealed dermal inflammation, ulceration, cellular infiltration, and reduced hair follicle density, with late effects of dermal indentations, excessive collagen, cellular inflammation, and persistent hair follicle loss (p < 0.05). The present murine model effectively replicated early and late RISR clinical and histological features for mechanistic investigations and developing therapeutic strategies in future studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.